Turn Therapeutics (TTRX) Operating Income (2024 - 2026)

Turn Therapeutics' Operating Income history runs 3 years deep, the most recent figure standing at -$1.2 million for Q1 2026.

• In Q1 2026, Operating Income fell 223.68% year-over-year to -$1.2 million; the TTM figure through Mar 2026 stood at -$5.7 million (changed N/A YoY), while the FY2025 annual figure was -$5.9 million, down 226.0% from the prior year.
• Operating Income was -$1.2 million for Q1 2026 at Turn Therapeutics, up from -$2.2 million in the prior quarter.
• In the past five years, Operating Income ranged from a high of -$328957.0 in Q4 2024 to a low of -$2.2 million in Q4 2025.
• Historically, Operating Income has averaged -$1.1 million across 3 years, with a median of -$959567.5 in 2024.
• Biggest YoY gain for Operating Income was 184.34% in 2025; the steepest drop was 566.83% in 2025.
• A 3-year view of Operating Income shows it stood at -$328957.0 in 2024, then sank by 566.83% to -$2.2 million in 2025, then soared by 43.19% to -$1.2 million in 2026.
• The last three Operating Income figures came in at -$1.2 million (Q1 2026), -$2.2 million (Q4 2025), and -$1.9 million (Q3 2025), per Business Quant data.